Abstract
Dorsal root ganglion stimulation (DRG-S) is effective in treating CRPS type I or II (causalgia) of the groin and lower extremities. Despite considerable efforts toward establishing biomarkers of pain, methods to measure pain are primarily focused on patient reported outcomes (PRO). This study will quantify changes in function, affect, sleep, and quality of life using a commercially available wearable device and correlate these objective metrics with patient-reported outcomes collected prior to and post permanent implant of a DRG-S system.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
